Immunohistochemical Detection of HIF-1α and CAIX in Advanced Head-and-Neck CancerMatthias Kappler, Matthias Bache, Gabriele Hänsgen et al.|Strahlentherapie und Onkologie|2008Cited by 41
Immunohistochemical Detection of HIF-1α and CAIX in Advanced Head-and-Neck CancerMatthias Kappler, Matthias Bache, Helge Täubert et al.|Strahlentherapie und Onkologie|2008Cited by 28
Hyperfractionated accelerated radiation therapy plus cetuximab plus cisplatin chemotherapy in locally advanced inoperable squamous cell carcinoma of the head and neckThomas Kuhnt, Jürgen Dunst, Andreas Schreiber et al.|Strahlentherapie und Onkologie|2017Cited by 8
Phase II trial of concomitant hyperfractionated-accelerated radiotherapy (HART) with cisplatin (Cis) plus cetuximab (Cet) for locoregionally advanced inoperable squamous cell carcinoma of the head and neck (LA SCCHN): Feasibility and 2-year OS.Thomas Kuhnt, Juergen Dunst, Andreas Schreiber et al.|Journal of Clinical Oncology|2013Cited by 3
Phase II-trial of concomitant hyperfractionated-accelerated radiotherapy (HART) with cisplatin (Cis) plus cetuximab (Cet) for locoregionally advanced inoperable squamous cell head and neck cancer: 5-year end resultsThomas Kuhnt, Juergen Dunst, Andreas Schreiber et al.|Annals of Oncology|2016Cited by 0